The effects of obesity on pulmonary function

A M Li1, D Chan, E Wong

  • 1Department of Paediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR. albertmli@cuhk.edu.hk

Insights

Obese children commonly show reduced lung volumes and impaired diffusion capacity. Lung function decline correlated with obesity measured by DEXA, not BMI.

Area of Science:

  • Pediatric Pulmonology
  • Obesity Research
  • Diagnostic Imaging

Background:

  • Childhood obesity is a growing public health concern.
  • Obesity can impact respiratory health, but specific pulmonary function abnormalities require elucidation.
  • Dual-energy X-ray absorptiometry (DEXA) offers a precise measure of body composition.

Purpose of the Study:

  • To identify prevalent pulmonary function abnormalities in obese children.
  • To investigate the relationship between obesity severity (using DEXA) and lung function impairment.

Main Methods:

  • Sixty-four obese children underwent spirometry, lung volume measurements, and diffusion capacity tests.
  • Body composition was assessed using DEXA scans, with trunk and subtotal fat mass as obesity indicators.
  • Standard physical examinations were performed.

Main Results:

  • Reduced functional residual capacity (FRC) in 46% and impaired diffusion capacity (DLco) in 33% were the most common findings.
  • Obstructive ventilatory defects were observed in 3 patients.
  • A significant negative correlation existed between reduced FRC and DEXA-measured adiposity, but not with BMI.

Conclusions:

  • Reduced static lung volumes (FRC) and diffusion capacity are common in obese children.
  • The degree of obesity, as measured by DEXA, correlated with reduced static lung volumes, highlighting the impact of adiposity on respiratory mechanics.
Abstract

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...